China’s WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to US drug maker Merck & Co for about US$500 million, ahead of potential US legislation that would restrict ...

WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese company seeks to enhance its margins while continuing to navigate ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares in WuXi AppTec (Shanghai, China) opened 10.5% higher on December 9 compared to the previous market close while shares of several Indian CDMOs fell when the news was revealed. If passed ...

(Reuters) -China's WuXi AppTec said on Tuesday its subsidiaries have signed a deal with U.S.-based private equity firm Altaris LLC for the sale of its cell and gene therapy manufacturing unit ...

Following a modern-day protagonist who travels back in time, it explores the mythology, history and culture of Wuxi and nearby regions through a variety of performing genres, including dance ...

The "lake-center utopia" project at the Lihu Lake Scenic Spot in Wuxi includes a record store with a collection of world music. [Photo by Hu Xiao/For China Daily] Huang is Wan's son-in-law ...

The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s manufacturing operations in Ireland. Facing increasing global pressure, WuXi ...

(Bloomberg) -- WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese company seeks to enhance its margins while continuing to navigate ...